MXPA03004251A - Derivados de benzodiazepina como moduladores del receptor gaba a. - Google Patents

Derivados de benzodiazepina como moduladores del receptor gaba a.

Info

Publication number
MXPA03004251A
MXPA03004251A MXPA03004251A MXPA03004251A MXPA03004251A MX PA03004251 A MXPA03004251 A MX PA03004251A MX PA03004251 A MXPA03004251 A MX PA03004251A MX PA03004251 A MXPA03004251 A MX PA03004251A MX PA03004251 A MXPA03004251 A MX PA03004251A
Authority
MX
Mexico
Prior art keywords
gaba
receptor modulators
benzodiazepine derivatives
receptor
compound
Prior art date
Application number
MXPA03004251A
Other languages
English (en)
Spanish (es)
Inventor
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MXPA03004251A publication Critical patent/MXPA03004251A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA03004251A 2000-11-16 2001-11-08 Derivados de benzodiazepina como moduladores del receptor gaba a. MXPA03004251A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00124332 2000-11-16
PCT/EP2001/012887 WO2002040487A2 (en) 2000-11-16 2001-11-08 Benzodiazepine derivatives as gaba a receptor modulators

Publications (1)

Publication Number Publication Date
MXPA03004251A true MXPA03004251A (es) 2003-09-22

Family

ID=8170315

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004251A MXPA03004251A (es) 2000-11-16 2001-11-08 Derivados de benzodiazepina como moduladores del receptor gaba a.

Country Status (40)

Country Link
US (1) US6743789B2 (cg-RX-API-DMAC7.html)
EP (1) EP1337535B1 (cg-RX-API-DMAC7.html)
JP (1) JP4088151B2 (cg-RX-API-DMAC7.html)
KR (1) KR100504300B1 (cg-RX-API-DMAC7.html)
CN (1) CN1191255C (cg-RX-API-DMAC7.html)
AR (1) AR031345A1 (cg-RX-API-DMAC7.html)
AT (1) ATE268776T1 (cg-RX-API-DMAC7.html)
AU (2) AU2002217007B2 (cg-RX-API-DMAC7.html)
BG (1) BG107817A (cg-RX-API-DMAC7.html)
BR (1) BR0115393A (cg-RX-API-DMAC7.html)
CA (1) CA2427576C (cg-RX-API-DMAC7.html)
CZ (1) CZ295256B6 (cg-RX-API-DMAC7.html)
DE (1) DE60103776T2 (cg-RX-API-DMAC7.html)
DK (1) DK1337535T3 (cg-RX-API-DMAC7.html)
EC (1) ECSP034607A (cg-RX-API-DMAC7.html)
ES (1) ES2220831T3 (cg-RX-API-DMAC7.html)
GC (1) GC0000375A (cg-RX-API-DMAC7.html)
GT (1) GT200100230A (cg-RX-API-DMAC7.html)
HR (1) HRP20030360A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0303281A3 (cg-RX-API-DMAC7.html)
IL (1) IL155813A0 (cg-RX-API-DMAC7.html)
JO (1) JO2359B1 (cg-RX-API-DMAC7.html)
MA (1) MA26962A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004251A (cg-RX-API-DMAC7.html)
MY (1) MY141675A (cg-RX-API-DMAC7.html)
NO (1) NO324706B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ525413A (cg-RX-API-DMAC7.html)
PA (1) PA8532401A1 (cg-RX-API-DMAC7.html)
PE (1) PE20020583A1 (cg-RX-API-DMAC7.html)
PL (1) PL362925A1 (cg-RX-API-DMAC7.html)
PT (1) PT1337535E (cg-RX-API-DMAC7.html)
RU (1) RU2278865C2 (cg-RX-API-DMAC7.html)
SI (1) SI1337535T1 (cg-RX-API-DMAC7.html)
SK (1) SK7232003A3 (cg-RX-API-DMAC7.html)
TR (1) TR200402073T4 (cg-RX-API-DMAC7.html)
TW (1) TWI239333B (cg-RX-API-DMAC7.html)
UY (1) UY27026A1 (cg-RX-API-DMAC7.html)
WO (1) WO2002040487A2 (cg-RX-API-DMAC7.html)
YU (1) YU35603A (cg-RX-API-DMAC7.html)
ZA (1) ZA200303435B (cg-RX-API-DMAC7.html)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
WO2004113321A1 (ja) * 2003-06-19 2004-12-29 Daiichi Pharmaceutical Co., Ltd. 選択的なアミノ置換基導入法
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
AU2005272627A1 (en) 2004-08-13 2006-02-23 Amgen Inc. Substituted benzofused heterocycles
AU2005293820B2 (en) 2004-10-12 2010-11-25 F. Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
RU2007114763A (ru) * 2004-10-20 2008-11-27 Ф.Хоффманн-Ля Рош Аг (Ch) Галогенозамещенные производные бензодиазепинов
CA2584259C (en) * 2004-10-20 2013-04-02 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
EP1828194B1 (en) 2004-12-14 2008-05-28 F. Hoffmann-Roche AG Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
US8510055B2 (en) 2005-08-03 2013-08-13 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
EP1924712B1 (en) * 2005-08-03 2018-10-03 The Johns Hopkins University Methods for characterizing and treating cognitive impairment in aging and disease
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
WO2009139916A1 (en) * 2008-05-16 2009-11-19 Synta Pharmaceuticals Corp. Tricyclic triazole compounds that modulate hsp90 activity
CA2739900C (en) 2008-11-18 2016-11-08 F. Hoffmann-La Roche Ag Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
SI2370441T1 (sl) * 2008-11-28 2013-12-31 F. Hoffmann-La Roche Ag Arilcikloheksiletri dihidrotetraazabenzoazulenov za uporabo kot antagonisti receptorja vazopresina V1A
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
CA2818025A1 (en) 2010-11-15 2012-05-24 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
EP2897963A4 (en) * 2012-09-21 2016-03-30 Uwm Res Foundation Inc Novel GABAA AGONISTS AND METHOD FOR USE TO COMBAT AIRWAY HYPER REAGIBILITY AND IGNITIONS IN ASTHMA
EP4032889A1 (en) * 2013-12-20 2022-07-27 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CA2990004C (en) 2015-06-19 2024-04-23 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US10059718B2 (en) * 2016-01-04 2018-08-28 Tabomedex Biosciences, LLC Fused quadracyclic compounds, compositions and uses thereof
US10973479B2 (en) 2016-05-16 2021-04-13 Canon Medical Systems Corporation X-ray diagnosis apparatus, X-ray diagnosis apparatus controlling method, and X-ray diagnosis system
BR112019012821A2 (pt) 2016-12-19 2019-11-26 Agenebio, Inc. derivados de benzodiazepina, composições e métodos para o tratamento do comprometimento cognitivo
US20180170941A1 (en) * 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102512548B1 (ko) 2017-12-22 2023-03-22 삼성디스플레이 주식회사 유기 전계 발광 소자 및 유기 전계 발광 소자용 함질소 화합물
AU2019288382B2 (en) * 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
KR102151969B1 (ko) * 2019-12-11 2020-09-04 주식회사 지투비 투과도 가변창의 제조방법 및 그에 의해 제조된 투과도 가변창
CN112979658B (zh) * 2021-02-22 2022-05-31 南湖实验室 一种氟马西尼的制备方法
AU2023324882A1 (en) 2022-08-19 2025-03-20 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK174086D0 (da) 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
TW201311B (cg-RX-API-DMAC7.html) 1991-06-17 1993-03-01 Hoffmann La Roche

Also Published As

Publication number Publication date
WO2002040487A3 (en) 2002-09-26
ES2220831T3 (es) 2004-12-16
ATE268776T1 (de) 2004-06-15
AU2002217007B2 (en) 2006-11-30
IL155813A0 (en) 2003-12-23
KR100504300B1 (ko) 2005-07-28
RU2003116895A (ru) 2005-02-20
ZA200303435B (en) 2004-08-05
GC0000375A (en) 2007-03-31
AU1700702A (en) 2002-05-27
NZ525413A (en) 2005-02-25
TR200402073T4 (tr) 2004-10-21
NO20032208D0 (no) 2003-05-15
DE60103776T2 (de) 2005-07-14
PA8532401A1 (es) 2002-08-26
BR0115393A (pt) 2004-07-06
PE20020583A1 (es) 2002-07-06
KR20030045192A (ko) 2003-06-09
EP1337535B1 (en) 2004-06-09
CN1474820A (zh) 2004-02-11
DK1337535T3 (da) 2004-10-25
SI1337535T1 (en) 2004-10-31
MY141675A (en) 2010-06-15
BG107817A (bg) 2004-07-30
GT200100230A (es) 2002-07-04
ECSP034607A (es) 2003-06-25
HUP0303281A2 (hu) 2004-01-28
HK1062442A1 (en) 2004-11-05
RU2278865C2 (ru) 2006-06-27
JO2359B1 (en) 2006-12-12
NO20032208L (no) 2003-05-15
PL362925A1 (en) 2004-11-02
YU35603A (sh) 2006-05-25
CZ20031597A3 (cs) 2003-11-12
CA2427576A1 (en) 2002-05-23
PT1337535E (pt) 2004-09-30
CA2427576C (en) 2007-11-06
CN1191255C (zh) 2005-03-02
DE60103776D1 (de) 2004-07-15
HUP0303281A3 (en) 2005-05-30
AR031345A1 (es) 2003-09-17
NO324706B1 (no) 2007-12-03
MA26962A1 (fr) 2004-12-20
JP4088151B2 (ja) 2008-05-21
CZ295256B6 (cs) 2005-06-15
US20020103371A1 (en) 2002-08-01
SK7232003A3 (en) 2004-03-02
US6743789B2 (en) 2004-06-01
UY27026A1 (es) 2002-06-20
HRP20030360A2 (en) 2005-04-30
TWI239333B (en) 2005-09-11
WO2002040487A2 (en) 2002-05-23
JP2004517070A (ja) 2004-06-10
EP1337535A2 (en) 2003-08-27

Similar Documents

Publication Publication Date Title
GC0000375A (en) Benzodiazepine derivatives as gaba a receptor modulators
MY138352A (en) Benzothiazole derivatives
CA2401229A1 (en) Aryl fused azapolycyclic compounds
BE2017C018I2 (cg-RX-API-DMAC7.html)
BG106585A (en) Kinase inhibitors as therapeutic agents
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
BG66085B1 (bg) Фенилаланинови производни
SE9904508D0 (sv) New compounds
MXPA04005886A (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitirptamina-6.
ATE360633T1 (de) N-substituierte hydromorphone und ihre anwendung
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
AU2001274806A1 (en) Sulfonamide derivatives
WO2002085853A3 (en) Heterocyclylalkoxy-, -alkylthio- and -alkylaminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
UA66866C2 (uk) Синтез морфолінових похідних
SE0101082D0 (sv) Novel use
EP1019047A4 (en) ANTITHROMBOTIC AGENTS
ATE216233T1 (de) Indolditerpen alkaloide
EE200300394A (et) GlyT-1 inhibiitorid
NO20014889D0 (no) Fremgangsmåte for fremstilling av medisinske midler
ZA200400824B (en) Pyridin-2-yl-methlyamine derivatives for treating opioid dependence.
AP2001002179A0 (en) 2-Aminocarbonyl-9h-purine derivatives.
SE9901338D0 (sv) Novel process

Legal Events

Date Code Title Description
FG Grant or registration